Considering Biosimilars in Patients Failing their Initial Biologic


Activity Info

Upon completion of the activity, participants should be able to explain the circumstances under which it is appropriate to initiate or switch a patient with a rheumatologic disease to a biosimilar.

CME/CE credit is no longer available for this activity.


Webinar | 0.25 - 15 mins | Internal Medicine | Rheumatology | Family Medicine | Nurse | Biosimilars | | Online | Pharmacist | 

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA

Newsletter Sign-Up

Your email: